<DOC>
	<DOCNO>NCT01190553</DOCNO>
	<brief_summary>This pilot study Maintenance Intravenous Treatment AMANTADINE patient PARKINSON 'S Disease well balance medical treatment .</brief_summary>
	<brief_title>Pilot Study Maintenance Therapy With Intravenous AMANTADINE</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Amantadine</mesh_term>
	<criteria>Patients idiopathic Parkinson disease Age &lt; 80 Patients motor improvement optimal treatment anti parkinson medication Patients moderate severe dyskinesia Patients PD side effect tolerate anti parkinson medication Age &gt; 80 Patients Parkinson syndrome , vascular parkinsonism druginduced parkinsonism Patients PD develop adverse reaction oral amantadine Contraindication amantadine treatment</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>amantadine</keyword>
	<keyword>parkinson disease</keyword>
	<keyword>dyskinesia</keyword>
</DOC>